Mistral AI's 3 billion euro funding might seem significant, but one company's financial win doesn't automatically prove the entire AI Act's viability.
We have such finite resources in the NHS; equating a single business success with a complex regulation's overall effectiveness just isn't realistic.
Think about it: just because one patient can afford a private MRI doesn't mean the local hospital's waiting lists are suddenly solved.
We need far more evidence of systemic impact and long-term consequences before drawing such conclusions.